About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT04947735

CYPRESS Efficacy and Safety Study Extension

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology ...

Lead sponsor: SightGlass Vision, Inc.•11 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

SightGlass Vision, Inc.

Age

6 - 17 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Previously a successfully completed participant in the CYPRESS study (NCT03623074) and having not exited this study for more than 30 days;
•Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day);
•Willingness to participate in the trial for up to 3 years without contact lens wear;
•The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form.

Exclusion Criteria

•Known allergy to proparacaine, tetracaine, or tropicamide.

Related studies

Artificial Intelligence for Highly Myopic Cataract

NCT06616506 · Cataract, High Myopia, and more

Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years

NCT07462897 · Myopia Progression

RECRUITINGPhase 3

The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

NCT07535749 · Myopia Progression

Comparison of Myopic Small Incision Lenticule Extraction (SMILE) With VISUMAX 500 Versus VISUMAX 800 Platforms

NCT07505264 · Myopia

Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K

NCT06278974 · Myopia, Cost-effectiveness Analysis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 20, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment200

Start dateJul 2021

Last updatedDec 20, 2024

Condition

Juvenile Myopia Myopia

Locations shown

Golden Optometric Group

Whittier, California

Omega Vision Center, PA

Longwood, Florida

Kannarr Eye Care

Pittsburg, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions